IC
CL icon

Inscription Capital’s Colgate-Palmolive CL Stock Holding History

Inscription Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.48M Buy
48,850
+708
+1% +$61.9K 0.4% 48
2026
Q1 		$4.1M Sell
48,142
-175
-0.4% -$15.6K 0.43% 38
2025
Q4 		$3.82M Buy
48,317
+11,837
+32% +$928K 0.39% 41
2025
Q3 		$2.92M Sell
36,480
-2,294
-6% -$196K 0.31% 47
2025
Q2 		$3.52M Buy
38,774
+2,467
+7% +$225K 0.51% 35
2025
Q1 		$3.27M Buy
+36,307
New +$3.25M 0.54% 36
2024
Q3 		$3.57M Sell
34,376
-2,337
-6% -$238K 0.53% 38
2024
Q2 		$3.56M Buy
36,713
+406
+1% +$37.5K 0.57% 33
2024
Q1 		$3.27M Buy
+36,307
New +$3.08M 0.54% 36
2022
Q3 		– Sell
-2,500
Closed -$200K – 209
2022
Q2 		$200K Buy
+2,500
New +$195K 0.04% 240
2021
Q3 		– Sell
-9,462
Closed -$770K – 238
2021
Q2 		$770K Buy
+9,462
New +$774K 0.09% 153
2019
Q2 		– Sell
-2,730
Closed -$187K – 126
2019
Q1 		$187K Buy
2,730
+786
+40% +$50.8K 0.1% 122
2018
Q4 		$116K Buy
+1,944
New +$122K 0.06% 155

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Inscription Capital's CL Position: Q2 2026 in Review

Inscription Capital increased its Colgate-Palmolive (CL) stake by 1.5% in Q2 2026, buying an estimated $61.9K and bringing the position to 48,850 shares worth $4.48M. The position accounts for 0.4% of the portfolio, ranked #48.

Inscription Capital first reported a position in CL in Q4 2018 and has held it in 13 quarters since. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Inscription Capital held 48,850 shares of Colgate-Palmolive worth $4.48M as of Q2 2026.
  • Inscription Capital bought 708 Colgate-Palmolive shares in Q2 2026, an estimated $61.9K.
  • Colgate-Palmolive made up 0.4% of Inscription Capital's portfolio in Q2 2026, its #48 holding.
  • Inscription Capital first reported a position in Colgate-Palmolive in Q4 2018 and has held it in 13 quarters since.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.